Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Fucosylated α1-acid glycoprotein as a biomarker to predict prognosis following tumor immunotherapy of patients with lung cancer.

Yokobori T, Yazawa S, Asao T, Nakazawa N, Mogi A, Sano R, Kuwano H, Kaira K, Shirabe K.

Sci Rep. 2019 Oct 10;9(1):14503. doi: 10.1038/s41598-019-51021-2.

PMID:
31601857
2.

High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors.

Nakazawa N, Yokobori T, Kaira K, Turtoi A, Baatar S, Gombodorj N, Handa T, Tsukagoshi M, Ubukata Y, Kimura A, Kogure N, Ogata K, Maeno T, Sohda M, Yajima T, Shimizu K, Mogi A, Kuwano H, Saeki H, Shirabe K.

Ann Surg Oncol. 2019 Sep 30. doi: 10.1245/s10434-019-07878-8. [Epub ahead of print]

PMID:
31571056
3.

High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer.

Hagiwara K, Harimoto N, Yokobori T, Muranushi R, Hoshino K, Gantumur D, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Hosouchi Y, Shirabe K.

Ann Surg Oncol. 2019 Aug 28. doi: 10.1245/s10434-019-07708-x. [Epub ahead of print]

PMID:
31463696
4.

Low IRBIT Levels Are Associated With Chemo-resistance in Gastric Cancer Patients.

Nakazawa N, Ogata K, Yokobori T, Ide M, Baatar S, Ubukata Y, Kimura A, Kogure N, Sohda M, Kuwano H, Saeki H, Shirabe K.

Anticancer Res. 2019 Aug;39(8):4111-4116. doi: 10.21873/anticanres.13569.

PMID:
31366495
5.

Fluorodeoxyglucose uptake is associated with low tumor-infiltrating lymphocyte levels in patients with small cell lung cancer.

Kasahara N, Kaira K, Yamaguchi K, Masubuchi H, Tsurumaki H, Hara K, Koga Y, Sakurai R, Higuchi T, Handa T, Oyama T, Yokobori T, Shimizu K, Asao T, Hisada T.

Lung Cancer. 2019 Aug;134:180-186. doi: 10.1016/j.lungcan.2019.06.009. Epub 2019 Jun 11.

PMID:
31319979
6.

β2-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer.

Kurozumi S, Kaira K, Matsumoto H, Hirakata T, Yokobori T, Inoue K, Horiguchi J, Katayama A, Koshi H, Shimizu A, Oyama T, Sloan EK, Kurosumi M, Fujii T, Shirabe K.

Breast Cancer Res Treat. 2019 Oct;177(3):603-610. doi: 10.1007/s10549-019-05341-6. Epub 2019 Jul 9.

PMID:
31290053
7.

FF-10832 enables long survival via effective gemcitabine accumulation in a lethal murine peritoneal dissemination model.

Higuchi T, Yokobori T, Takahashi R, Naito T, Kitahara H, Matsumoto T, Kakinuma C, Hagiwara S, Kuwano H, Shirabe K, Asao T.

Cancer Sci. 2019 Sep;110(9):2933-2940. doi: 10.1111/cas.14123. Epub 2019 Aug 1.

8.

Multidisciplinary Therapy for Locally Advanced Oesophageal Cancer With Special Reference to Surgical Conversion and Salvage.

Sohda M, Miyazaki T, Sakai M, Kumakura Y, Honjyo H, Hara K, Tanaka N, Yokobori T, Shirabe K.

Anticancer Res. 2019 Jun;39(6):3167-3175. doi: 10.21873/anticanres.13454.

PMID:
31177163
9.

Role of Amino Acid Transporter Expression as a Prognostic Marker in Patients With Surgically Resected Colorectal Cancer.

Ogawa H, Kaira K, Motegi Y, Yokobori T, Takada T, Katoh R, Osone K, Takahashi R, Katayama C, Oyama T, Kanai Y, Yao T, Asao T, Kuwano H, Shirabe K.

Anticancer Res. 2019 May;39(5):2535-2543. doi: 10.21873/anticanres.13375.

PMID:
31092450
10.

Evaluation of KRAS Mutation Status in a Patient With Concomitant Pancreatic Neuroendocrine Neoplasm and Intraductal Papillary Mucinous Neoplasm.

Igarashi T, Harimoto N, Nobusawa S, Yoshida Y, Yamanaka T, Hagiwara K, Hoshino K, Ishii N, Tsukagoshi M, Watanabe A, Kubo N, Araki K, Yokobori T, Yokoo H, Shirabe K.

Pancreas. 2019 May/Jun;48(5):e34-e35. doi: 10.1097/MPA.0000000000001286. No abstract available.

PMID:
31090662
11.

Docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for patients with cervical esophageal cancer: a single-center retrospective study.

Sakai M, Sohda M, Saito H, Kuriyama K, Yoshida T, Kumakura Y, Hara K, Yokobori T, Miyazaki T, Murata K, Noda SE, Nakano T, Kuwano H, Shirabe K.

Cancer Chemother Pharmacol. 2019 Jun;83(6):1121-1126. doi: 10.1007/s00280-019-03835-0. Epub 2019 Apr 9.

PMID:
30972455
12.

Successful resection of intrahepatic cholangiocarcinoma with idiopathic thrombocytopenic purpura using thrombopoietin receptor agonist: a case report.

Hoshino K, Harimoto N, Muranushi R, Araki K, Yamanaka T, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Yokobori T, Shirabe K.

Surg Case Rep. 2019 Apr 10;5(1):56. doi: 10.1186/s40792-019-0619-4.

13.

Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma.

Iijima M, Yokobori T, Mogi A, Shimizu K, Yajima T, Kosaka T, Ohtaki Y, Obayashi K, Nakazawa S, Gombodorj N, Tsukagoshi M, Shirabe K, Kuwano H.

Ann Surg Oncol. 2019 Jun;26(6):1744-1750. doi: 10.1245/s10434-019-07268-0. Epub 2019 Mar 28.

PMID:
30924018
14.

Stathmin-1 Is a Useful Diagnostic Marker for High-Grade Lung Neuroendocrine Tumors.

Shimizu K, Goto Y, Kawabata-Iwakawa R, Ohtaki Y, Nakazawa S, Yokobori T, Obayashi K, Kawatani N, Yajima T, Kaira K, Mogi A, Hirato J, Nishiyama M, Shirabe K.

Ann Thorac Surg. 2019 Jul;108(1):235-243. doi: 10.1016/j.athoracsur.2019.02.040. Epub 2019 Mar 22.

PMID:
30910656
15.

Carbonic anhydrase 9 expression is associated with poor prognosis, tumor proliferation, and radiosensitivity of thymic carcinomas.

Ohtaki Y, Shimizu K, Kawabata-Iwakawa R, Gombodorj N, Altan B, Rokudai S, Yamane A, Kaira K, Yokobori T, Nagashima T, Obayashi K, Nakazawa S, Iijima M, Kosaka T, Yajima T, Mogi A, Kuwano H, Shirabe K, Nishiyama M.

Oncotarget. 2019 Feb 12;10(13):1306-1319. doi: 10.18632/oncotarget.26657. eCollection 2019 Feb 12.

16.

Post-treatment Glasgow Prognostic Score Predicts Efficacy in Advanced Non-small-cell Lung Cancer Treated With Anti-PD1.

Kasahara N, Sunaga N, Tsukagoshi Y, Miura Y, Sakurai R, Kitahara S, Yokobori T, Kaira K, Mogi A, Maeno T, Asao T, Hisada T.

Anticancer Res. 2019 Mar;39(3):1455-1461. doi: 10.21873/anticanres.13262.

PMID:
30842182
17.

Plastin3 is associated with epithelial-mesenchymal transition and poor prognosis in gastric cancer.

Kurashige J, Yokobori T, Mima K, Sawada G, Takahashi Y, Ueo H, Takano Y, Matsumura T, Uchi R, Eguchi H, Sudo T, Sugimachi K, Mori M, Baba H, Mimori K.

Oncol Lett. 2019 Feb;17(2):2393-2399. doi: 10.3892/ol.2018.9819. Epub 2018 Dec 11.

18.

Carboxypeptidase A4 accumulation is associated with an aggressive phenotype and poor prognosis in triple-negative breast cancer.

Handa T, Katayama A, Yokobori T, Yamane A, Fujii T, Obayashi S, Kurozumi S, Kawabata-Iwakawa R, Gombodorj N, Nishiyama M, Asao T, Shirabe K, Kuwano H, Oyama T.

Int J Oncol. 2019 Mar;54(3):833-844. doi: 10.3892/ijo.2019.4675. Epub 2019 Jan 4.

19.

Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts.

Ishii N, Araki K, Yokobori T, Hagiwara K, Gantumur D, Yamanaka T, Handa T, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Harimoto N, Masamune A, Umezawa K, Kuwano H, Shirabe K.

Cancer Sci. 2019 Jan;110(1):334-344. doi: 10.1111/cas.13847. Epub 2018 Dec 13.

20.

ASO Author Reflections: Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma.

Kumakura Y, Yokobori T, Sohda M, Shirabe K, Kuwano H.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):741-742. doi: 10.1245/s10434-018-6903-x. Epub 2018 Oct 12. No abstract available.

PMID:
30315381
21.

High stromal transforming growth factor β-induced expression is a novel marker of progression and poor prognosis in gastric cancer.

Suzuki M, Yokobori T, Gombodorj N, Yashiro M, Turtoi A, Handa T, Ogata K, Oyama T, Shirabe K, Kuwano H.

J Surg Oncol. 2018 Nov;118(6):966-974. doi: 10.1002/jso.25217. Epub 2018 Sep 9.

PMID:
30260476
22.

Correlation between high FBXW7 expression in pretreatment biopsy specimens and good response to chemoradiation therapy in patients with locally advanced esophageal cancer: A retrospective study.

Gombodorj N, Yokobori T, Tanaka N, Suzuki S, Kuriyama K, Kumakura Y, Yoshida T, Sakai M, Sohda M, Baatar S, Miyazaki T, Nishiyama M, Shirabe K, Kuwano H.

J Surg Oncol. 2018 Jul;118(1):101-108. doi: 10.1002/jso.25127. Epub 2018 Aug 11.

PMID:
30098297
23.

A novel one-step lens cleaning device using air and water flow for endoscopic surgery.

Tatsuki H, Yokobori T, Katayama C, Kato R, Takahashi R, Osone K, Takada T, Yajima R, Motegi Y, Ogawa H, Fujii T, Shirabe K, Kuwano H, Asao T.

PLoS One. 2018 Jul 18;13(7):e0200749. doi: 10.1371/journal.pone.0200749. eCollection 2018.

24.

High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma.

Shimoda Y, Ubukata Y, Handa T, Yokobori T, Watanabe T, Gantumur D, Hagiwara K, Yamanaka T, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Araki K, Harimoto N, Katayama A, Hikino T, Sano T, Ogata K, Kuwano H, Shirabe K, Oyama T.

BMC Cancer. 2018 May 25;18(1):597. doi: 10.1186/s12885-018-4503-6.

25.

Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma.

Kasahara N, Kaira K, Bao P, Higuchi T, Arisaka Y, Erkhem-Ochir B, Sunaga N, Ohtaki Y, Yajima T, Kosaka T, Oyama T, Yokobori T, Asao T, Nishiyama M, Tsushima Y, Kuwano H, Shimizu K, Mogi A.

Lung Cancer. 2018 May;119:71-77. doi: 10.1016/j.lungcan.2018.03.001. Epub 2018 Mar 16.

PMID:
29656756
26.

Multimodality Therapy Including Proton Beam Therapy for AFP Producing Esophageal Cancer with Multiple Liver Metastases.

Miyazaki T, Sohda M, Sakai M, Kumakura Y, Yoshida T, Kuriyama K, Yokobori T, Miyazaki M, Hirato J, Okumura T, Ishikawa H, Sakurai H, Kuwano H.

Intern Med. 2018 Aug 15;57(16):2333-2339. doi: 10.2169/internalmedicine.0270-17. Epub 2018 Mar 30.

27.

Innovative methodology for the identification of soluble biomarkers in fresh tissues.

Costanza B, Turtoi A, Bellahcène A, Hirano T, Peulen O, Blomme A, Hennequière V, Mutijima E, Boniver J, Meuwis MA, Josse C, Koopmansch B, Segers K, Yokobori T, Fahmy K, Thiry M, Coimbra C, Garbacki N, Colige A, Baiwir D, Bours V, Louis E, Detry O, Delvenne P, Nishiyama M, Castronovo V.

Oncotarget. 2018 Jan 31;9(12):10665-10680. doi: 10.18632/oncotarget.24366. eCollection 2018 Feb 13.

28.

Elucidation of the Anatomical Mechanism of Nodal Skip Metastasis in Superficial Thoracic Esophageal Squamous Cell Carcinoma.

Kumakura Y, Yokobori T, Yoshida T, Hara K, Sakai M, Sohda M, Miyazaki T, Yokoo H, Handa T, Oyama T, Yorifuji H, Kuwano H.

Ann Surg Oncol. 2018 May;25(5):1221-1228. doi: 10.1245/s10434-018-6390-0. Epub 2018 Feb 23.

29.

Investigation into metastatic processes and the therapeutic effects of gemcitabine on human pancreatic cancer using an orthotopic SUIT-2 pancreatic cancer mouse model.

Higuchi T, Yokobori T, Naito T, Kakinuma C, Hagiwara S, Nishiyama M, Asao T.

Oncol Lett. 2018 Mar;15(3):3091-3099. doi: 10.3892/ol.2017.7722. Epub 2017 Dec 29.

30.

High expression of carcinoembryonic antigen and telomerase reverse transcriptase in circulating tumor cells is associated with poor clinical response to the immune checkpoint inhibitor nivolumab.

Bao H, Bai T, Takata K, Yokobori T, Ohnaga T, Hisada T, Maeno T, Bao P, Yoshida T, Kumakura Y, Honjo H, Sakai M, Sohda M, Fukuchi M, Altan B, Handa T, Ide M, Miyazaki T, Ogata K, Oyama T, Shimizu K, Mogi A, Asao T, Shirabe K, Kuwano H, Kaira K.

Oncol Lett. 2018 Mar;15(3):3061-3067. doi: 10.3892/ol.2017.7671. Epub 2017 Dec 20.

31.

Development of single nanometer-sized ultrafine oxygen bubbles to overcome the hypoxia-induced resistance to radiation therapy via the suppression of hypoxia-inducible factor‑1α.

Iijima M, Gombodorj N, Tachibana Y, Tachibana K, Yokobori T, Honma K, Nakano T, Asao T, Kuwahara R, Aoyama K, Yasuda H, Kelly M, Kuwano H, Yamanouchi D.

Int J Oncol. 2018 Mar;52(3):679-686. doi: 10.3892/ijo.2018.4248. Epub 2018 Jan 18.

32.

High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer.

Suzuki K, Watanabe A, Araki K, Yokobori T, Harimoto N, Gantumur D, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Kubo N, Gombodorj N, Nishiyama M, Hosouchi Y, Kuwano H, Shirabe K.

Anticancer Res. 2018 Feb;38(2):939-944.

PMID:
29374725
33.

Association of Preoperative Nutritional Status with Prognosis in Patients with Esophageal Cancer Undergoing Salvage Esophagectomy.

Sakai M, Sohda M, Miyazaki T, Yoshida T, Kumakura Y, Honjo H, Hara K, Ozawa D, Suzuki S, Tanaka N, Yokobori T, Kuwano H.

Anticancer Res. 2018 Feb;38(2):933-938.

PMID:
29374724
34.

Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1.

Ishii N, Araki K, Yokobori T, Gantumur D, Yamanaka T, Altan B, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Hosouchi Y, Kuwano H, Shirabe K.

Oncotarget. 2017 Nov 6;8(68):112636-112646. doi: 10.18632/oncotarget.22634. eCollection 2017 Dec 22.

35.

A new enzyme immunoassay for the determination of highly sialylated and fucosylated human α1-acid glycoprotein as a biomarker of tumorigenesis.

Yazawa S, Yokobori T, Kaira K, Kuwano H, Asao T.

Clin Chim Acta. 2018 Mar;478:120-128. doi: 10.1016/j.cca.2017.12.030. Epub 2017 Dec 21.

PMID:
29274330
36.

Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases.

Blomme A, Van Simaeys G, Doumont G, Costanza B, Bellier J, Otaka Y, Sherer F, Lovinfosse P, Boutry S, Palacios AP, De Pauw E, Hirano T, Yokobori T, Hustinx R, Bellahcène A, Delvenne P, Detry O, Goldman S, Nishiyama M, Castronovo V, Turtoi A.

Oncogene. 2018 Mar;37(9):1237-1250. doi: 10.1038/s41388-017-0018-x. Epub 2017 Dec 15.

PMID:
29242606
37.

Postprandial cardiogenic syncope caused by gastric polyp-induced pyloric obstruction in an elderly woman with a giant hiatal hernia: a case report.

Saito H, Miyazaki T, Sohda M, Sakai M, Honjyo H, Kumakura Y, Yoshida T, Yokobori T, Kurosawa K, Kuwano H.

Surg Case Rep. 2017 Dec 13;3(1):124. doi: 10.1186/s40792-017-0403-2.

38.

Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis.

Kimura A, Ogata K, Altan B, Yokobori T, Mochiki E, Yanai M, Kogure N, Yanoma T, Suzuki M, Bai T, Kuwano H.

World J Gastroenterol. 2017 Nov 14;23(42):7541-7550. doi: 10.3748/wjg.v23.i42.7541.

39.

Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma.

Altan B, Kaira K, Watanabe A, Kubo N, Bao P, Dolgormaa G, Bilguun EO, Araki K, Kanai Y, Yokobori T, Oyama T, Nishiyama M, Kuwano H, Shirabe K.

Cancer Chemother Pharmacol. 2018 Jan;81(1):141-153. doi: 10.1007/s00280-017-3477-4. Epub 2017 Nov 17.

PMID:
29149426
40.

18F-FAMT PET Is Useful to Distinguish between Specific Uptake and Nonspecific Uptake Compared to 18F-Flourodeoxyglucose Position Emission Tomography in Esophageal Cancer Patients.

Sohda M, Miyazaki T, Honjyo H, Hara K, Ozawa D, Sakai M, Yokobori T, Higuchi T, Tsushima Y, Kuwano H.

Dig Surg. 2018;35(5):383-388. doi: 10.1159/000480122. Epub 2017 Nov 2.

PMID:
29130979
41.

High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma.

Bao P, Yokobori T, Altan B, Iijima M, Azuma Y, Onozato R, Yajima T, Watanabe A, Mogi A, Shimizu K, Nagashima T, Ohtaki Y, Obayashi K, Nakazawa S, Bai T, Kawabata-Iwakawa R, Asao T, Kaira K, Nishiyama M, Kuwano H.

Ann Surg Oncol. 2017 Dec;24(13):4017-4024. doi: 10.1245/s10434-017-6083-0. Epub 2017 Sep 20.

PMID:
28933054
42.

Elevated expression of ΔNp63 in advanced esophageal squamous cell carcinoma.

Kumakura Y, Rokudai S, Iijima M, Altan B, Yoshida T, Bao H, Yokobori T, Sakai M, Sohda M, Miyazaki T, Nishiyama M, Kuwano H.

Cancer Sci. 2017 Nov;108(11):2149-2155. doi: 10.1111/cas.13394. Epub 2017 Oct 3.

43.

Metabolic activity by 18F-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC.

Kaira K, Higuchi T, Naruse I, Arisaka Y, Tokue A, Altan B, Suda S, Mogi A, Shimizu K, Sunaga N, Hisada T, Kitano S, Obinata H, Yokobori T, Mori K, Nishiyama M, Tsushima Y, Asao T.

Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):56-66. doi: 10.1007/s00259-017-3806-1. Epub 2017 Aug 21.

PMID:
28828507
44.

Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients.

Obayashi S, Horiguchi J, Higuchi T, Katayama A, Handa T, Altan B, Bai T, Bao P, Bao H, Yokobori T, Nishiyama M, Oyama T, Kuwano H.

Int J Oncol. 2017 Sep;51(3):781-790. doi: 10.3892/ijo.2017.4085. Epub 2017 Jul 27.

45.

Clinical Significance and Phenotype of MTA1 Expression in Esophageal Squamous Cell Carcinoma.

Honjo H, Toh Y, Sohda M, Suzuki S, Kaira K, Kanai Y, Nagamori S, Oyama T, Yokobori T, Miyazaki T, Kuwano H.

Anticancer Res. 2017 Aug;37(8):4147-4155.

PMID:
28739699
46.

Heat shock-induced HIKESHI protects cell viability via nuclear translocation of heat shock protein 70.

Yanoma T, Ogata K, Yokobori T, Ide M, Mochiki E, Toyomasu Y, Yanai M, Kogure N, Kimura A, Suzuki M, Nakazawa N, Bai T, Oyama T, Asao T, Shirabe K, Kuwano H.

Oncol Rep. 2017 Sep;38(3):1500-1506. doi: 10.3892/or.2017.5844. Epub 2017 Jul 21.

PMID:
28731175
47.

High expression of nucleobindin 2 is associated with poor prognosis in gastric cancer.

Altan B, Kaira K, Okada S, Saito T, Yamada E, Bao H, Bao P, Takahashi K, Yokobori T, Tetsunari O, Nishiyama M, Yamada M.

Tumour Biol. 2017 Jul;39(7):1010428317703817. doi: 10.1177/1010428317703817.

PMID:
28714371
48.

Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients.

Handa T, Katayama A, Yokobori T, Yamane A, Horiguchi J, Kawabata-Iwakawa R, Rokudai S, Bao P, Gombodorj N, Altan B, Kaira K, Asao T, Kuwano H, Nishiyama M, Oyama T.

J Surg Oncol. 2017 Nov;116(6):706-715. doi: 10.1002/jso.24705. Epub 2017 Jun 1.

PMID:
28570747
49.

Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy.

Ishii N, Araki K, Yokobori T, Watanabe A, Tsukagoshi M, Kubo N, Suzuki H, Saito F, Altan B, Hosouchi Y, Shirabe K, Kuwano H.

Oncol Lett. 2017 May;13(5):3653-3661. doi: 10.3892/ol.2017.5946. Epub 2017 Mar 29.

50.

Inhibition of Ubiquitin-conjugating Enzyme E2 May Activate the Degradation of Hypoxia-inducible Factors and, thus, Overcome Cellular Resistance to Radiation in Colorectal Cancer.

Gombodorj N, Yokobori T, Yoshiyama S, Kawabata-Iwakawa R, Rokudai S, Horikoshi I, Nishiyama M, Nakano T.

Anticancer Res. 2017 May;37(5):2425-2436.

PMID:
28476810

Supplemental Content

Loading ...
Support Center